Viracta Therapeutics Inc
NASDAQ:VIRX 3:59:51 PM EDT
Viracta Therapeutics Inc Stock, NASDAQ:VIRX
2533 South Coast Highway 101, Suite 210, Cardiff, California 92007
United States of America
Phone: +1.858.400.8470
Number of Employees: 8
Description
Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-associated malignancies. It develops antiviral agent valganciclovir as an oral combination therapy which is in a Phase 2 clinical trial for EBV-positive lymphomas. The company was founded on February 10, 1998 and is headquartered in Cardiff, CA.